Esrum Biotech Holding ApS: Financial statements 2024
CVR: 44827662
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Esrum Biotech Holding ApS (CVR 44827662) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -20,425 and a net result of DKK 1,236,174. Equity in the 2024 report amounted to DKK 3,623,149. The solvency ratio was 56.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -20,425
- Profit/Loss
- DKK 1,236,174
- Equity
- DKK 3,623,149
- Total Assets
- DKK 6,460,992
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of May 27, 2024, Mette Kirstine Agger is registered as an owner of Esrum Biotech Holding ApS with an ownership share of 20%.
As of May 27, 2024, Nis Peter Agger is registered as an owner of Esrum Biotech Holding ApS with an ownership share of 33%.
As of May 27, 2024, Søren Thye Agger is registered as an owner of Esrum Biotech Holding ApS with an ownership share of 33%.
As of April 25, 2024, Mette Kirstine Agger is registered as director of Esrum Biotech Holding ApS.
Esrum Biotech Holding ApS was founded on April 25, 2024.
About Esrum Biotech Holding ApS
Esrum Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2024. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Mette Kirstine Agger. The company is owned by Mette Kirstine Agger, Nis Peter Agger and Søren Thye Agger. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -9,172 and a net result of DKK -193,617 compared with DKK 1,236,174 the year before. Equity in the 2025 report amounted to DKK 3,429,532.